http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6060599-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e0f4f8190960626ec922a1f03bcd4aba
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D501-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-00
filingDate 1998-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2000-05-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_82cffe73fc337d82e5f492213e0bacdb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_faa9a5ea071c3b0e6701959d2572fc76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e1f196ffb8d41fc6949d0d2e087d5f7f
publicationDate 2000-05-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-6060599-A
titleOfInvention Process for the preparation of cefuroxime axetil in an amorphous form
abstract A process for preparing cefuroxime axetil in substantially amorphous form comprises forming a mixture of crystalline cefuroxime axetil and at least one pharmaceutically acceptable excipient, and subjecting the mixture to milling for a period of time sufficient to convert the crystalline cefuroxime axetil to substantially amorphous form, i.e., the crystallinity is less than 5%. The amorphous cefuroxime axetil has a chemical purity of at least 95%. Desirably, the particles of the milled material are reduced to a size of less than 2 mu m. The amorphous cefuroxime axetil prepared by this method may consist of R isomer, S isomer, or a racemic mixture of the R and S isomers.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7507813-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6346530-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006020130-A1
priorityDate 1997-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5013833-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5847118-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5118799-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4820833-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9843980-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4562181-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4267320-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4994567-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448380735
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226426202
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226710517
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128267996
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6321416
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226425685
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87060545
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226425684
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57280286
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453467280
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5361467
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226426203
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6604560
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136251628
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393946
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457707758
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3423265
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5234
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5361202
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448670727
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226425683
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419581658
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID41375
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24261
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10112
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426080684

Total number of triples: 53.